Alpha-1 Antitrypsin Deficiency.
Stoller JK, Hupertz V, Aboussouan LS.
2006 Oct 27 [updated 2023 Jun 1]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024.
Alpha1-antitrypsin deficiency and asthma.
Pini L, Paoletti G, Heffler E, Tantucci C, Puggioni F; Asthma and Alpha1-Antitrypsin Research Group.
Curr Opin Allergy Clin Immunol. 2021 Feb 1;21(1):46-51. doi: 10.1097/ACI.0000000000000711.
New Directions in Pulmonary Gene Therapy.
Vu A, McCray PB , Jr.
Hum Gene Ther. 2020 Sep;31(17-18):921-939. doi: 10.1089/hum.2020.166.
Therapeutic SERPINs: Improving on Nature.
Maas C, de Maat S.
Front Cardiovasc Med. 2021 Mar 31;8:648349. doi: 10.3389/fcvm.2021.648349. eCollection 2021.
Alpha-1 Antitrypsin Deficiency: Have We Got the Right Proteinase?
Stockley RA.
Chronic Obstr Pulm Dis. 2020 Jul;7(3):163-171. doi: 10.15326/jcopdf.7.3.2019.0151.
Alpha-1 antitrypsin augmentation therapy.
Wewers MD, Crystal RG.
COPD. 2013 Mar;10 Suppl 1:64-7. doi: 10.3109/15412555.2013.764402.
Lessons from the Past: Some Histories of Alpha-1 Antitrypsin Deficiency Before Its Discovery.
Perciaccante A, Charlier P, Negri C, Coralli A, Appenzeller O, Bianucci R.
COPD. 2018 Feb;15(1):1-3. doi: 10.1080/15412555.2017.1421151.
Augmentation therapy of alpha-1 antitrypsin deficiency associated emphysema.
Traclet J, Delaval P, Terrioux P, Mornex JF.
Rev Mal Respir. 2015 Apr;32(4):435-46. doi: 10.1016/j.rmr.2014.10.001. Epub 2015 Apr 20.
Airway disease in alpha-1 antitrypsin deficiency.
Strange C.
COPD. 2013 Mar;10 Suppl 1:68-73. doi: 10.3109/15412555.2013.764404.
Gene therapy for alpha-1 antitrypsin deficiency.
Flotte TR, Mueller C.
Hum Mol Genet. 2011 Apr 15;20(R1):R87-92. doi: 10.1093/hmg/ddr156. Epub 2011 Apr 16.
